Nordic communications consulting company Geelmuyden Kiese (GK) has partnered with Danish IT and software company KMD to provide smart and efficient COVID-19 test solutions for the sports and entertainment industries.
The tests are already being used in the top tier of Danish football, the Superliga, which returned to action last week.
Medical technology company Qlife, with the support of KMD, has adapted its biomarker test technology to perform COVID-19 testing. The technology, known as Egoo Health, is being used to carry out tests in the Superliga and could also be implemented across other sports, as well as film productions and event organisations.
Geelmuyden Kiese has been appointed partner of the Egoo Health technology to help event organisers and leagues return to action following COVID-19.
Ronnie Hansen, director of sports, culture and entertainment at Geelmuyden Kiese, said: “At Geelmuyden Kiese we are an active participant in the industry and cherish the opportunity to help professional event and league organisers return to business as soon as possible.
“The opportunities with the test kit from Qlife/KMD are great news for everyone in the sports, culture, and entertainment business. They now have an opportunity to reopen under controlled circumstances without risking the health of the participants.”
Christian Binggeli-Winter, vice-president of data, information management and analytics at KMD, added: “We are extremely pleased that with our expertise in medical and computer technology we can offer a simple and secure test method.
“We are proud to have played our role in reopening the Danish professional football league, and we hope that our collaboration with Geelmuyden Kiese can help us get in touch with other leagues, organisations or events with similar needs for a testing solution.”